High prevalence of tetracycline resistance in Neisseria gonorrhoeae across 22 European countries, 2024
In 2024, based on the European Committee on Antimicrobial Susceptibility Testing breakpoint, we observed a tetracycline resistance prevalence of 62.3% (2,231/3,579) in <i>Neisseria gonorrhoeae</i> isolates from 22 European countries (range: 16.5-100%). Multivariable analysis of correlations between resistance and patients' epidemiological characteristics found tetracycline resistance associated with men who have sex with men (aOR: 1.38; 95% CI: 1.06-1.79). Our results are important when considering measures against transmission of sexually transmitted bacterial infections in Europe, such as in the context of doxycycline post-exposure prophylaxis (doxy-PEP).
Authors
- M Unemo
- Melissa Jansen van Rensburg
- Csaba Ködmön (ORCID: https://orcid.org/0000-0001-8040-6753)
- Otilia Mårdh (ORCID: https://orcid.org/0000-0002-0581-9838)
- the Euro-GASP tetracycline study group
- Daniel Schröder
- Michelle J Cole
Institutions
- Örebro University (SE)
- Collaborative Research Group (AU)
- UK Health Security Agency (GB)
- University College London (GB)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2807/1560-7917.es.2026.31.2.2500965
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00